ITGA1 and neoplasm: Antibodies and OT-1 T cells were administered as indicated in Figure 6A. While control mice (treated with isotype antibodies) showed adequately delayed tumor growth, we observed significantly impaired tumor control in mice treated with either anti-VLA-1 (Figure 6B) or anti-CD103 (Figure 6C) antibodies.